4EBP1 |
Eukaryotic translation initiation factor 4E-binding protein 1 |
ALK |
Anaplastic lymphoma kinase |
Bad |
Bcl-2-associated death promotor |
CIP2A |
Cancerous inhibitor of PP2A |
CML |
Chronic myeloid leukaemia |
CT |
Computed tomography |
EC |
Endometrial carcinoma |
EGFR |
Epidermal growth factor receptor |
ERK |
Extracellular signal-regulated kinase |
FDA |
US Food and Drug Administration |
FIGO |
International Federation of Obstetrics and Gynaecology |
FOXO |
Forkhead box |
GSK-3β |
Glycogen synthase kinase 3β |
HER-2 |
Human epidermal growth factor receptor 2 |
IRS-1 |
Insulin receptor substrate 1 |
MAPK |
Mitogen-activated protein kinase |
MEK |
Mitogen-activated protein kinase kinase |
MRI |
Magnetic resonance imaging |
MSI |
Microsatellite instability |
mTOR |
Mammalian target of rapamycin |
NSCLC |
Non-small cell lung cancer |
OA |
Okadaic acid |
Pap |
Papanicolaou |
PI3K |
Phosphatidylinositol-4,5-bisphosphate 3-kinase |
PIK3IP1 |
PI3K interacting protein 1 |
PIP2
|
Phosphatidylinositol 4,5-bisphosphate |
PIP3
|
Phosphatidylinositol 3,4,5-trisphosphate |
PME-1 |
PP2A methylesterase 1 |
POLE |
Polymerase ε |
PP2A |
Protein phosphatase 2A |
ProMisE |
Proactive Molecular Risk Classifier for Endometrial Cancer |
PTEN |
Phosphatase and tensin homolog |
PTPA |
Phosphatase 2A phosphatase activator |
RTK |
Receptor tyrosine kinase |
S6 |
Ribosomal protein S6 |
SCF |
Skp, Cullin, F-box |
SET |
Suvar/Enhancer of zeste/Trithorax |
SMAP |
Small molecular activator of PP2A |
SV40 |
Simian virus 40 |
T-ALL |
T-cell acute lymphoblastic leukaemia |
TCGA |
The Cancer Genome Atlas |
TVU |
Transvaginal ultrasound |